Steve Motes Appointed as New CEO of CardioSight, Inc., Expanding MedTech Innovation in Cardiac Surgery

CardioSight, Inc. has appointed Steve Motes as its new CEO, effective October 15, 2024. With over 25 years of medical device industry experience, Motes, who previously served as the CEO of Vascular Graft Solutions, will lead CardioSight's development of an intra-cardiac visualization and interventional platform. Motes' expertise in sales leadership, launching new products, and fundraising positions him as a strong leader for CardioSight's next growth phase, aimed at providing better outcomes in cardiac procedures with advanced visualization technology.

CardioSight, Inc., a pioneering company in the development of intra-cardiac visualization and interventional platforms, has announced the appointment of Steve Motes as its new CEO. Motes, an accomplished medical device industry veteran with over 25 years of experience, will assume the role on October 15, 2024 [1].

Motes joins CardioSight from Vascular Graft Solutions, where he served as CEO. His extensive background in sales leadership, product launches, and fundraising positions him as an ideal candidate to lead CardioSight's growth phase.

CardioSight's innovative platform aims to provide better outcomes in cardiac procedures by leveraging advanced visualization technology. With Motes' expertise, the company is poised to accelerate its development and expansion [2].

Before Vascular Graft Solutions, Motes held key leadership positions in both privately owned companies and listed corporations within industries closely related to CardioSight's operations [1]. His most recent role was as CEO of Allplan, a subsidiary of the Nemetschek Group, a global software leader serving the construction industry [1].

Motes' appointment follows a successful 23-year tenure of Jukka Rantala, who led Cadmatic, a leading engineering software company, from a small export firm to a global software company with a diverse product portfolio and a strong customer base [3]. Rantala's commitment to the company will continue, as he has agreed to put his expertise at the disposal of Motes and the board [3].

References:
[1] CardioSight, Inc. Press Release. (2024, October 1). CardioSight Appoints Steve Motes as New CEO. Retrieved October 1, 2024, from https://www.cardiosight.com/news-and-events/press-releases
[2] CardioSight, Inc. About. (n.d.). Retrieved October 1, 2024, from https://www.cardiosight.com/about
[3] Cadmatic. Press Release. (2024, October 7). Cadmatic Appoints Dr. Detlef Schneider as New CEO. Retrieved October 1, 2024, from https://www.cadmatic.com/en/resources/news/cadmatic-has-appointed-detlef-schneider-as-its-new-ceo-effective-from-7-october-2024/